BNT314
BNT314-01
Phase 1 small_molecule active
Quick answer
BNT314 for Advanced or metastatic malignant solid tumors is a Phase 1 program (small_molecule) at BioNTech Manufacturing GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BioNTech Manufacturing GmbH
- Indication
- Advanced or metastatic malignant solid tumors
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active